Viz.ai today announced a collaboration with NICO Corporation to help improve the lives of patients with intracerebral hemorrhages.
Intracerebral hemorrhage (ICH) is caused by bleeding in the brain tissue and is a life-threatening type of stroke. It accounts for up to 15% of all strokes and has high morbidity and mortality rates.
Viz-ai’s technology can help hospitals detect suspected diseases earlier and allow for accurate volume measurements of brain bleeds, which can be crucial for determining the severity of cases. NICO’s technology gives early and safe access to the brain with BrainPath and maximal evacuation of the clot using Myriad. The two companies’ technologies will increase efficiencies and enhance patient care.
“The results of the ENRICH trial have finally shown positive treatment data on one of the most costly and deadly diseases,” Viz.ai CEO Dr. Chris Mansi said in a news release. “We’re excited to collaborate with NICO, leveraging our broadly deployed AI platform to assist neurosurgeons in their decision making and improve patient outcomes post intracerebral hemorrhage.”
The results of the ENRICH trial showed that early minimally invasive parafascicular surgery intervention was safe and superior to guideline-based medical management alone, using NICO’s BrainPath and Myriad technology.
Viz.ai’s AI-powered ICH Plus module will allow hospitals and health systems to automate the process of identifying, labeling, and determining the volume of segmentable brain structures on non-contrast computed tomography images. According to the company, the technology can be incorporated seamlessly into the workflows of radiologists, neurologists, and neurosurgeons.
“The combination of our patented technologies, the collaboration with Viz.ai and the results of the ENRICH trial are transforming the way that ICH is treated,” NICO President and CEO Jim Pearson said. “The AI modules, Viz ICH and Viz ICH Plus, are a welcomed enhancement to patient care by leveraging AI-powered care coordination, getting patients the care they need, when they need it most.”